Skip to main content

and
  1. Article

    Open Access

    Prednisolone and rapamycin reduce the plasma cell gene signature and may improve AAV gene therapy in cynomolgus macaques

    Adeno-associated virus (AAV) vector gene therapy is a promising approach to treat rare genetic diseases; however, an ongoing challenge is how to best modulate host immunity to improve transduction efficiency a...

    Alexander Kistner, Jessica A. Chichester, Lili Wang, Roberto Calcedo in Gene Therapy (2024)

  2. Article

    Open Access

    Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration

    The development of liver-based adeno-associated virus (AAV) gene therapies is facing concerns about limited efficiency and durability of transgene expression. We evaluated nonhuman primates following intraveno...

    Jenny A. Greig, Kelly M. Martins, Camilo Breton in Nature Biotechnology (2023)